Characteristic | Willing to prescribe n (%) | OR (95% CI) | P-value |
---|---|---|---|
Country | |||
England (n= 651) | 524 (80.5) | 1.17 (0.37 to 3.18) | 0.771 |
Wales (n= 21) | 16 (76.2) | Reference | Reference |
Gender | |||
Female (n= 373) | 297 (79.6) | Reference | Reference |
Male (n= 290) | 238 (82.1) | 0.94 (0.61 to 1.46) | 0.793 |
Another identitya (n= 1) | 0 (0.0) | – | 0.994 |
Non-binarya (n= 1) | 1 (100.0) | – | 0.996 |
Prefer not to say (n= 7) | 4 (57.1) | 0.27 (0.05 to 1.48) | 0.105 |
GP status | |||
Salaried/locum GP (n= 389) | 307 (78.9) | 1.00 (0.62 to 1.58) | 0.988 |
GP partner (n= 233) | 193 (82.8) | Reference | Reference |
GP retainersa (n= 3) | 3 (100.0) | – | 0.991 |
GP specialist trainee (n= 44) | 34 (77.3) | 1.22 (0.51 to 3.10) | 0.667 |
Othera (n= 3) | 3 (100.0) | – | 0.992 |
Years qualified | |||
0–4 years (n= 24) | 20 (83.3) | Reference | Reference |
5–9 years (n= 151) | 114 (75.5) | 0.47 (0.13 to 1.39) | 0.205 |
10–14 years (n= 174) | 133 (76.4) | 0.52 (0.14 to 1.51) | 0.263 |
15–19 years (n= 143) | 114 (79.7) | 0.61 (0.16 to 1.83) | 0.409 |
≥20 years (n= 180) | 159 (88.3) | 1.04 (0.27 to 3.23) | 0.952 |
Specialism | |||
Cancer (n= 37) | 34 (91.9) | 1.75 (0.56 to 7.67) | 0.387 |
Family history (n= 28) | 21 (75.0) | 0.58 (0.23 to 1.59) | 0.256 |
Geneticsa (n= 4) | 4 (100.0) | – | 0.989 |
Preventive medicine (n= 87) | 69 (79.3) | 0.72 (0.39 to 1.38) | 0.312 |
Other (n= 132) | 104 (78.8) | 0.74 (0.44 to 1.26) | 0.258 |
N/A — no specialty (n= 384) | 308 (80.2) | Reference | Reference |
Previous experience | |||
Consulted a patient with LS | |||
Consulted – yes (n= 311) | 261 (83.9) | 1.57 (0.99 to 2.50) | 0.055 |
Consulted – unsure (n= 112) | 90 (80.4) | 1.23 (0.69 to 2.27) | 0.497 |
Consulted – no (n= 249) | 189 (75.9) | Reference | Reference |
Discussed aspirin with a patient with LS | |||
Discussed aspirin – yes (n= 61) | 57 (93.4) | 0.81 (0.21 to 3.57) | 0.763 |
Discussed aspirin – unsure (n= 28) | 23 (82.1) | 0.37 (0.10 to 1.53) | 0.153 |
Discussed aspirin – no (n= 583) | 460 (78.9) | Reference | Reference |
Prescribed aspirin to a patient with LS | |||
Prescribed aspirin – yes (n= 73) | 68 (93.2) | 2.34 (0.72 to 9.05) | 0.183 |
Prescribed aspirin – unsure (n= 40) | 37 (92.5) | 5.67 (1.37 to 34.71) | 0.032 |
Prescribed aspirin – no (n= 559) | 435 (77.8) | Reference | Reference |
Awareness | |||
Prior awareness of aspirin in LS population | |||
Yes (n= 300) | 261 (87.0) | 1.49 (0.91 to 2.49) | 0.118 |
No (n= 372) | 279 (75.0) | Reference | Reference |
Prior awareness of NICE guidance NG151 | |||
Yes (n= 117) | 107 (91.5) | 1.74 (0.80 to 4.07) | 0.177 |
No (n= 555) | 433 (78.0) | Reference | Reference |
Result in bold is significant.
↵a OR (95% CI) not reported because of insufficient cases. CI = confidence interval.
LS = Lynch syndrome. N/A = not applicable. NICE = National Institute for Health and Care Excellence. OR = odds ratio.